147 related articles for article (PubMed ID: 37816645)
1. Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study.
Romanowska J; Bjornevik K; Cortese M; Tuominen JA; Solheim M; Abolpour Mofrad A; Igland J; Scherzer CR; Riise T
Neurology; 2023 Nov; 101(21):e2068-e2077. PubMed ID: 37816645
[TBL] [Abstract][Full Text] [Related]
2. Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study.
Zenesini C; Baldin E; Vignatelli L; Poluzzi E; Antonazzo I; Calandra-Buonaura G; Guarino M; De Carolis P; Cortelli P; D'Alessandro R;
J Neurol Sci; 2019 Oct; 405():116421. PubMed ID: 31422283
[TBL] [Abstract][Full Text] [Related]
3. Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort Study.
Portugal B; Artaud F; Domenighetti C; Roze E; Degaey I; Canonico M; Elbaz A
Neurology; 2023 Jan; 100(3):e324-e335. PubMed ID: 36192171
[TBL] [Abstract][Full Text] [Related]
4. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Urate and the risk of Parkinson's disease in men and women.
Cortese M; Riise T; Engeland A; Ascherio A; Bjørnevik K
Parkinsonism Relat Disord; 2018 Jul; 52():76-82. PubMed ID: 29615298
[TBL] [Abstract][Full Text] [Related]
7. Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis.
Paakinaho A; Koponen M; Tiihonen M; Kauppi M; Hartikainen S; Tolppanen AM
Neurology; 2022 Mar; 98(12):e1273-e1281. PubMed ID: 35064025
[TBL] [Abstract][Full Text] [Related]
8. NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database study.
Brakedal B; Tzoulis C; Tysnes OB; Haugarvoll K
PLoS One; 2021; 16(9):e0256602. PubMed ID: 34492069
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study.
Alves G; Müller B; Herlofson K; HogenEsch I; Telstad W; Aarsland D; Tysnes OB; Larsen JP;
J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):851-7. PubMed ID: 19246476
[TBL] [Abstract][Full Text] [Related]
10. Association of Physical Activity and Parkinson Disease in Women: Long-term Follow-up of the E3N Cohort Study.
Portugal B; Artaud F; Degaey I; Roze E; Fournier A; Severi G; Canonico M; Proust-Lima C; Elbaz A
Neurology; 2023 Jul; 101(4):e386-e398. PubMed ID: 37197993
[TBL] [Abstract][Full Text] [Related]
11. Statin Use and Incidence of Parkinson's Disease in Women from the French E3N Cohort Study.
Nguyen TTH; Fournier A; Courtois É; Artaud F; Escolano S; Tubert-Bitter P; Boutron-Ruault MC; Degaey I; Roze E; Canonico M; Ahmed I; Thiébaut ACM; Elbaz A
Mov Disord; 2023 May; 38(5):854-865. PubMed ID: 36788159
[TBL] [Abstract][Full Text] [Related]
12. Association Between Parkinson Disease and Risk of Cancer in Taiwan.
Lin PY; Chang SN; Hsiao TH; Huang BT; Lin CH; Yang PC
JAMA Oncol; 2015 Aug; 1(5):633-40. PubMed ID: 26181771
[TBL] [Abstract][Full Text] [Related]
13. Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease.
Simmering JE; Welsh MJ; Liu L; Narayanan NS; Pottegård A
JAMA Neurol; 2021 Apr; 78(4):407-413. PubMed ID: 33523098
[TBL] [Abstract][Full Text] [Related]
14. Aromatase inhibitors and the incidence of Parkinson disease: A population-based cohort study.
Khosrow-Khavar F; Azoulay L; Montastruc JL; Montastruc F; Renoux C
Cancer; 2022 Jun; 128(12):2339-2347. PubMed ID: 35363379
[TBL] [Abstract][Full Text] [Related]
15. Heart rate variability and the risk of Parkinson disease: The Atherosclerosis Risk in Communities study.
Alonso A; Huang X; Mosley TH; Heiss G; Chen H
Ann Neurol; 2015 May; 77(5):877-83. PubMed ID: 25707861
[TBL] [Abstract][Full Text] [Related]
16. Risk of Parkinson's disease following severe constipation: a nationwide population-based cohort study.
Lin CH; Lin JW; Liu YC; Chang CH; Wu RM
Parkinsonism Relat Disord; 2014 Dec; 20(12):1371-5. PubMed ID: 25293395
[TBL] [Abstract][Full Text] [Related]
17. The natural history of depressive symptoms in patients with incident Parkinson's disease: a prospective cohort study.
Larsen JP; Dalen I; Pedersen KF; Tysnes OB
J Neurol; 2017 Dec; 264(12):2401-2408. PubMed ID: 29032408
[TBL] [Abstract][Full Text] [Related]
18. What predicts mortality in Parkinson disease?: a prospective population-based long-term study.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
Neurology; 2010 Oct; 75(14):1270-6. PubMed ID: 20921512
[TBL] [Abstract][Full Text] [Related]
19. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.
Engeland A; Bramness JG; Daltveit AK; Rønning M; Skurtveit S; Furu K
Br J Clin Pharmacol; 2008 May; 65(5):653-60. PubMed ID: 18294334
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease.
Heinzel S; Aho VTE; Suenkel U; von Thaler AK; Schulte C; Deuschle C; Paulin L; Hantunen S; Brockmann K; Eschweiler GW; Maetzler W; Berg D; Auvinen P; Scheperjans F
Ann Neurol; 2020 Aug; 88(2):320-331. PubMed ID: 32441370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
